Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. (ARTV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARTV · as of Jun 9, 2026
Key Statistics
Explore Artiva Biotherapeutics, Inc. Data
artv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The ARTV analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $37.50, representing +451.47% upside from the current price of $6.80.
Competitors & Peers
artv competitorsARTV
ADVM
ALXO
CNTB
DTIL
GUTSStock Performance
Full HistoryAbout Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and…
what is artiva biotherapeutics, inc. · artv stock overview · artiva biotherapeutics, inc. company profile · who is artiva biotherapeutics, inc. ceo · artv NASDAQ · artiva biotherapeutics, inc. headquarters · artiva biotherapeutics, inc. business segments
About Stock Overview & Key Data
Artiva Biotherapeutics, Inc. (ARTV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 19, 2024. As of the latest trading session, ARTV stock price is $6.80, with a market capitalization of $168.1M. The stock has returned +222.27% over the past 12 months and +58.51% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Artiva Biotherapeutics, Inc. stock is Buy, with an average 12-month price target of $37.50. In fiscal year 2025, Artiva Biotherapeutics, Inc. reported revenue of — and net income of -$83.9M. For detailed data — including Artiva Biotherapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Artiva Biotherapeutics, Inc. (ARTV) stock price is $6.80. The stock is traded on NASDAQ under the ticker symbol ARTV. The 52-week range is $1.47 – $14.53.